← Leaderboards
Chris L Kepley
Luna Innovations, Inc.
$3,174,446
Attributed
$3,174,446
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $757.2K · FY2008–23$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,174,446 · 5
By mechanism
R01$1,492,637 · 1
R15$826,892 · 2
R21$555,726 · 1
R43$299,191 · 1
Top collaborators
No co-investigators on record.
Most similar at Luna Innovations, Inc.
Same institution · by research overlap
- Zhiguo Zhou$2,751,379
- Valeriy Bezmelnitsyn$224,997
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsMonitorAffectFullerenesNanomaterialsIn VitroDiagnosisMast CellAntigensMolecularFoundationsKineticsPeripheral BloodMediatingEffector CellCell TypeAllergicBasophilsCarbonAutoimmune DiseasesInflammationAsthmaHypersensitivity
Grant awards (12)
Human mast cells as a platform for new cancer immunotherapy strategies$372,846
R15 · FY2023 · CA · contact PI
Studies examining quantitative in vivo imaging of breast cancer-targeted, therapeutic human mast cells$263,686
R15 · FY2020 · CA · contact PI
Studies examining quantitative in vivo imaging of breast cancer-targeted,therapeutic human mast cells$190,360
R15 · FY2020 · CA · contact PI
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease$292,053
R01 · FY2012 · GM · contact PI
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease$292,053
R01 · FY2011 · GM · contact PI
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease$295,003
R01 · FY2010 · GM · contact PI
Prevention of Allergic Disease Using Nanomaterials$263,269
R21 · FY2010 · ES · contact PI
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease$315,714
R01 · FY2009 · GM · contact PI
Prevention of Allergic Disease Using Nanomaterials$292,457
R21 · FY2009 · ES · contact PI
Development of Glioblastoma-Targeting Endofullerenes for Imaging Brain Tumors$149,032
R43 · FY2009 · CA · contact PI
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease$297,814
R01 · FY2008 · GM · contact PI
Development of Glioblastoma-Targeting Endofullerenes for Imaging Brain Tumors$150,159
R43 · FY2008 · CA · contact PI